Objectives. ANCAs with specificity for MPO are serological markers of ANCA-associated vasculitides, especially microscopic polyangiitis (MPA). This study investigated potential associations between the influence of MPO-ANCA on the oxidation activity of MPO and the clinical manifestations as well as immunological characteristics of MPO-ANCA.
Introduction
ANCAs are serological markers of ANCA-associated vasculitis (AAV), comprising WG, microscopic polyangiitis (MPA), Churg-Strauss syndrome and renal limited vasculitis [1] . The two most common target antigens of ANCA are PR3 and MPO. PR3-ANCA and MPO-ANCA are common in WG and MPA, respectively, although such a relationship is not always the case, especially in Chinese patients [2, 3] .
The pathogenic role of MPO-ANCA has been demonstrated by a number of studies. The most direct clinical evidence is a case of neonatal MPA secondary to transfer of maternal MPO-ANCA resulting in neonatal pulmonary haemorrhage and renal involvement [4] . The best evidence of animal studies is from a mouse model, following immunization of MPO-knockout (Mpo À / À ) mice with mouse MPO; the direct pathogenic effect of MPO-ANCA in AAV has been convincingly demonstrated by passive transfer of anti-MPO immunoglobulin (IgG) alone into recombinase-activating gene-2-deficient (Rag2 and wild-type mice [5] . MPO-ANCA can mediate the interactions between cytokine-primed neutrophils and endothelium and then enhance the degranulation and production of superoxide, pro-inflammatory cytokines of neutrophils [6, 7] .
MPO-ANCA can also influence the activity of MPO. As an enzyme, MPO contributes to the bactericidal capabilities of mammalian neutrophils and monocytes. The major function of MPO is to convert chloride (Cl) to hypochlorous acid (HOCl) [8] , so that the uncontrolled activity of MPO is harmful. It has been suggested by Guilpain et al. [9] that MPO-ANCA per se could activate MPO directly. On the other hand, there are also some studies suggesting contrary results. Griffin et al. [10] found that MPO-ANCA from 5 out of 21 patients with AAV inhibited the MPO activity in vitro. This was further confirmed by our previous study on propylthiouracil-induced ANCA-positive vasculitis [11] .
Whether such activation or inhibition of MPO by MPO-ANCA is potentially associated with clinical manifestations is not clear. The purpose of the current study is to investigate the potential clinical significance of the influence of MPO activity by affinity-purified MPO-ANCA from patients with MPA.
Materials and methods

Patients and plasma
Plasma from 13 consecutive patients with MPO-ANCApositive MPA who received plasma exchange treatment, in Peking University First Hospital from December 1998 to December 2009, was collected. All the patients fulfilled the Chapel Hill Consensus Conference (CHCC) definition of MPA [12] and had complete clinical data. Patients with secondary vasculitis or with anti-GBM antibodies were excluded. The indications of plasma exchange were severe pulmonary haemorrhage or dialysis-dependent acute renal failure at presentation attributable to active vasculitis [13] . Normal plasma was collected from 20 normal blood donors. All the plasma was collected at presentation and stored at À20 C until use. The research was in compliance of the Declaration of Helsinki and approved by the ethics committee of the local hospital (Peking University First Hospital). Written informed consent was obtained from each patient.
ANCA tests were performed by both IIF assay and antigen-specific ELISA. Standard IIF assays were performed according to the manufacturer's instructions (Euroimmun, Lü beck, Germany). Two highly purified known ANCA antigens, PR3 and MPO, purified as previously reported [14] , was used as solid-phase ligands in ELISA. The results of ELISA were expressed as percentages of a known positive control.
Purification of MPO-ANCA with MPO-affinity chromatography
The plasma was centrifuged for 20 min (10 397 g, 4 C). The supernatant was loaded onto a protein-G agarose affinity column (Pharmacia, Uppsala, Sweden) with a flow rate of 1 ml/min. Bound IgG was eluted and neutralized immediately, and then dialyzed against 0.01 M PBS (pH 7.4). The concentration of IgG was measured with spectrophotometry (Beckman, Brea, CA) at 280 nm. Purified native MPO (5 mg) [14] was coupled to 5 ml cyanogen bromide-activated Sepharose 4B gel (Amersham Pharmacia, Uppsala, Sweden) with 0.1 mol/l NaHCO 3 and 0.5 mol/l NaCl, pH 8.3 as coupling buffer at room temperature for 2 h and blocked with 0.2 mol/l glycine (pH 8.0 at room temperature for 2 h). IgG from patients were applied to the affinity column coupled with purified native MPO in 0.3 ml/min with 0.01 mol/l PBS (pH 7.4) as starting buffer and 0.1 mol/l glycine, 0.5 mol/l NaCl (pH 2.7) as eluting buffer, at a speed of 1 ml/min at room temperature. The eluate was neutralized to pH 7.0, concentrated and dialyzed against PBS.
Detection of titres of MPO-ANCA Highly purified human native MPO was coated to the wells of a polystyrene microtitre plate (Nunc Immunoplate; Nunc, Roskilde, Denmark) at 2.0 mg/ml in coating buffer (0.05 mol/l bicarbonate buffer, pH 9.6). The volume in each well was 100 ml in all steps, unless otherwise stated. Each sample was tested in duplication. All the incubations were carried out at 37 C for 1 h, and the plates were washed three times with PBS containing 0.1% Tween-20 (PBST) (Chemical Reagents, Beijing, China) between stages. Affinity-purified MPO-ANCA at a concentration equivalent to original plasma was diluted at 1 : 50 with PBST. Every plate contained positive, negative and blank controls (PBST). Binding was detected with ALP-conjugated goat anti-human IgG (Fc specific; Sigma, St Louis, MO, USA) at a dilution of 1 : 20 000. The P-nitrophenyl phosphate (pNPP, 1 mg/ml; Sigma) was used in substrate buffer [1 M diethanolamine and 0.5 mM MgCl 2 (pH 9.8)]. The results were recorded as the absorbance (A) at 405 nm (A 405 nm) and samples were considered positive if the A 405 nm exceeded mean (3 S.D.) of the A 405 nm of IgG that was diluted at the concentration of 2 mg/l from 20 normal blood donors. IgG from normal blood donors were diluted to 2 mg/l because this concentration was equivalent to the affinity-purified MPO-ANCA after being diluted at 1 : 50. Samples positive for MPO-ANCA in screening were subsequently tested at 2-fold dilutions, from 1 : 50 to 1 : 25 600, to determine their titres.
Detection of avidity constant of MPO-ANCA
The avidity constant (aK) of MPO-ANCA was determined as described as the reciprocal value of molar concentration of MPO in the liquid phase resulting in 50% inhibition of antibody binding. Briefly, the antibodies concentrations required for competitive assay were first determined by being diluted in PBST, in order to give the same absorbance units (net A 0.7). The competitive binding assay was performed by incubating the diluted antibodies with increasing amounts of native MPO (from 0.1 to 100 mg/ml) in PBST, for 2 h at 37 C. The diluted anti-MPO antibodies www.rheumatology.oxfordjournals.org
were then transferred to MPO-coated plates for the standard ELISA procedure.
Detection of MPO-ANCA subclasses
Detection of MPO-ANCA IgG subclasses were performed in the same ELISA system as described above, except that after antibody incubation, monoclonal mouse anti-human IgG subclass antibodies (clone 4E3 for IgG1, Hp6014 for IgG2, HP6050 for IgG3, HP6025 for IgG4; Southern Biotech, Birmingham, AL, USA) were added with a dilution at 1 : 4000, 1 : 1000, 1 : 1000 and 1 : 2000 in PBST, respectively. Then ALP-conjugated goat anti-mouse IgG (Fc specific; Sigma) diluted at 1 : 20 000 was added. Different dilutions of four anti-human IgG subclasses antibodies were selected because the A-values of positive controls could achieve $1.5 in 10 min.
Measurement of MPO oxidation activity and the influence of affinity-purified MPO-ANCA
The assay for MPO oxidation activity was adapted from the procedure described by Hassan et al. [15] with some minor modifications. Purified MPO was diluted at 2 mg/ml in Dulbecco's PBS (0.20 g/l of KCl, 0.20 g/l of KH 2 PO 4 , 8 g/l of NaCl, 1.15 g/l of Na 2 HPO 4 ) and coated onto 96-well Costar Microtiter Plate (Data Packaging Corporation, Cambridge, MA, USA) overnight at 4 C in duplicate. After three washes with PBS, 100 ml of 0.1 mg/ml affinity-purified MPO-ANCA in PBS from each patient was added in duplicate, and the plates were incubated at 37 C for 60 min. After three washes with PBS, 0.4 mg/ml of o-phenylenediamine and 0.88 mM H 2 O 2 in 0.05 M citrate buffer (pH 5.0) were added. After 10 min, the A-value was measured at 450 nm with a reference wavelength of 630 nm using a microplate reader. The oxidation activity of MPO was expressed by the A-value at 10 min. The average A-value of 20 coats with only PBS was calculated as control.
Effect of MPO-ANCA on the interaction between MPO and ceruloplasmin
Ceruloplasmin is a 130-kDa serum acute-phase reaction protein and is thought to be the physical inhibitor of MPO. The binding of ceruloplasmin to MPO could be prevented by MPO-ANCA [10] . So we compared the ability of MPO-ANCA from different patients at preventing the binding between ceruloplasmin and MPO. The method was adapted from the procedure described by Nolle et al. [16] with some minor modifications. Purified MPO was diluted at 2 mg/ml in 0.05 mol/l bicarbonate buffer (pH 9.6) overnight at 4 C. Then the following substrates were added: 100 mg/ ml purified anti-MPO antibody with 125 mg/ml human ceruloplasmin (Sigma) in PBST, goat anti-ceruloplasmin sera with 1 : 1000 dilution and ALP-conjugated rabbit anti-goat IgG (Sigma) with 1 : 20 000 dilution. All were diluted with PBST at 37 C for 1 h. Plates were washed with PBST between stages. The colour development was measured spectrophotometrically at 405 nm with pNPP as substrate. The concentration of 125 mg/ml was about one-third of the physical concentration of ceruloplasmin in normal people, this concentration was selected because the A-value could get about 1.5 in 10 min.
Statistical analysis
Quantitative data were expressed as mean (S.D.). Titres of antibodies were expressed as the lgT. The aK was expressed as reciprocal value of molar concentration of MPO used in antigen-inhibition ELISA. The Pearson test was used for correlation analysis. It was considered to be significant difference if P < 0.05. Analyses were performed with SPSS statistical software package (version 11; SPSS, Chicago, IL, USA).
Results
General data of the patients (Fig. 1) .
Effect of MPO-ANCA on MPO oxidation activity
Without binding to MPO-ANCA, the activity of MPO was 1.521 (0.120) (expressed as A-values at 10 min) ( Fig. 2A) . After binding to affinity-purified MPO-ANCA, the activity of MPO (expressed as A-values) ranged from 1.038 to 1.642 (Fig. 2B) .
Effect of MPO-ANCA on the interaction between MPO and ceruloplasmin
Without adding MPO-ANCA, the A-value of ceruloplasmin binding on MPO was 1.482 (0.028). All the MPO-ANCA at a concentration of 100 mg/ml could decrease the binding between ceruloplasmin and MPO, but to different extents (expressed by A-value, from 0.634 to 1.323) (Fig. 3) .
Correlation between the oxidation activity of MPO after binding MPO-ANCA and clinical characteristics
Correlation analysis showed that after binding to MPO-ANCA, the oxidation activity of MPO correlated with initial sera creatinine levels (r = À0.564, P = 0.045) and BVAS (r = À0.735, P = 0.004), respectively (Fig. 4) . The ANCA level was expressed as the net A-value at 405 nm in ELISA with MPO-ANCA diluted at 1 : 50 equivalent to the original plasma. Scr: serum creatinine; K: kidney; L: lung or respiratory system; G: gastrointestinal tract; J: joint; N: nervous system; A: absorbance; F: female; M: male.
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Influence of MPO by MPO-ANCA and disease activity
Correlation between the oxidation activity of MPO after binding MPO-ANCA and immunological characteristics of MPO-ANCA Correlation analysis showed that after binding MPO-ANCA, the oxidation activity of MPO correlated with the avidity of MPO-ANCA (r = À0.575, P = 0.040), levels of MPO-ANCA-IgG2 (r = À0.610, P = 0.027) and IgG3 subclass (r = À0.695, P = 0.008) and the level of ceruloplasmin binding on MPO in the presence of MPO-ANCA (expressed as A-value) (r = 0.617, P = 0.025) (Fig. 5) .
Discussion
The components in the blood are complex, and there may be something that can bind MPO-ANCA-IgG other than free MPO in sera, such as the anti-idiotypic antibody. Therefore, when investigating the relationship between MPO and MPO-ANCA, it is convincing to use affinitypurified MPO-ANCA [10] . In the current study, those patients with MPO-ANCA resulting in low MPO activity had severe clinical presentations (high level of initial serum creatinine and BVAS), high avidity of MPO-ANCA and high levels of MPO-ANCA-IgG2 and IgG3. There are different results about the relationship between avidity of MPO-ANCA and clinical characteristics of patients in previous studies [17] [18] [19] . Kokolina et al. [17] found that, in patients with MPA, the avidity of MPO-ANCA did not correlate with the organ involvement or serum creatinine; but Gao et al. [18] found that the avidity of MPO-ANCA was associated with elevated ESR and BVAS. Regarding the subclass distribution of MPO-ANCA in MPA, there were also several studies with almost consistent results [20] [21] [22] . In patients with kidney involvement, the IgG3 levels were higher than those in patients without kidney involvement [20] . This was consistent with the results of the current study.
In this study, the MPO-ANCA with different avidity and different subclass distribution could influence MPO activity to different extents. The high avidity of MPO-ANCA indicates tight binding of MPO-ANCA to MPO, and this will influence the conformational change of MPO molecules, which is necessary for enzymes during catalysis of biochemical reactions. Among the four subclasses of IgG, IgG3 had the strongest avidity [20] , so the high-level IgG3 might contribute to the high avidity of MPO-ANCA. IgG3 also had the longest and Influence of MPO by MPO-ANCA and disease activity most flexible hinge region [23] among the four subclasses, so that after binding MPO, MPO-ANCA-IgG3 might cover the enzyme active centre on MPO with its flexible Fc fragment and then prevent the entry of substrate into the active centre. Besides the high avidity and high MPO-ANCA-IgG3 level, another factor that will influence the heterogeneity of the MPO-ANCA is epitope recognition. It has been found that there are various epitopes on the MPO molecule which may be recognized by MPO-ANCA from different patients [24, 25] . Whether the different influence on MPO activity by MPO-ANCA from different patients in the current study was due to the different epitope recognition (especially the epitopes with different distances from enzyme activity centre on MPO) needs further investigation.
In AAV, PR3-ANCA and MPO-ANCA are not only biomarkers but also pathogenic factors. Although the activation of MPO was thought to be harmful, the inhibition of MPO oxidation activity by MPO-ANCA was not found to be protective in the current study. This result is similar to the study on WG, in which the inhibitory anti-PR3 antibodies were found more frequently in active diseases than in remission [26] . Actually, MPO has multiple pathogenic effects in MPA. As an enzyme, MPO can catalyze the production of HOCl. As an autoantigen, MPO can bind MPO-ANCA, and neutrophils can subsequently be activated [7] . So the total pathogenic effect of the MPO-ANCA after binding MPO is complicated. MPO can be inhibited by ceruloplasmin in physical status. This binding can be reversed by MPO-ANCA. In the current study, the oxidation activity of MPO after binding MPO-ANCA positively correlated with the level of ceruloplasmin binding on MPO in the presence of antibody, and negatively correlated with the avidity of MPO-ANCA. So the MPO-ANCA with higher avidity had stronger ability to compete with ceruloplasmin to bind MPO and to reverse the binding between ceruloplasmin and MPO, as compared with the MPO-ANCA with lower avidity. Therefore, in the presence of the MPO-ANCA with higher avidity, the MPO will lose more inhibition by ceruloplasmin and then will have the ability to injure the target tissue slowly with the remaining oxidation activity. This pathogenic effect might compensate the decrease of MPO activity induced by the MPO-ANCA with higher avidity.
In conclusion, MPO-ANCA from different patients can influence MPO activity to different extents. There are relationships between the influence of MPO-ANCA on oxidation activity of MPO and clinical manifestations. The low oxidation activity of MPO after binding MPO-ANCA might be associated with more severe disease. Further investigation is needed to enlarge the sample size to confirm these results.
Rheumatology key messages
. MPO-ANCA from different patients can influence MPO activity to different extents. . The low oxidation activity of MPO after binding MPO-ANCA might be associated with more severe disease.
